The role of triacylglycerols and repurposing DGAT1 inhibitors for the treatment of Mycobacterium tuberculosis. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.tcsw.2022.100083
PubMed Identifier: 36277080
Publication URI: http://europepmc.org/abstract/MED/36277080
Type: Journal Article/Review
Volume: 8
Parent Publication: Cell surface (Amsterdam, Netherlands)
ISSN: 2468-2330